Board Meeting13 Aug 2026, 04:17 pm
Omkar Pharmachem Board Approves Unaudited Q1 FY27 Results
AI Summary
Omkar Pharmachem Ltd announced that its Board of Directors met on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company also received the Limited Review Report from its auditors, Dipal R. Shah & Co., for the same period. The financial results indicate a net loss for the quarter. The meeting commenced at 3:30 PM and concluded at 4:10 PM.
Key Highlights
- Board meeting held on August 13, 2026.
- Unaudited financial results for Q1 FY27 approved.
- Limited Review Report received from auditors.
- Results indicate a net loss for the quarter.
- Meeting duration was 40 minutes.
Price Impact
More from OMKARPH